Dioxin-mediated tumor progression through activation of mitochondria-to-nucleus stress signaling

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 1, 2008, Pages 186-191

  Biswas, Gopa ^a   Srinivasan, Satish ^a   Anandatheerthavarada, Hindupur K ^a   Avadhani, Narayan G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzodioxin (TCDD); Calcineurin; Mitochondrial transcription; Transmembrane potential; Tumor invasion

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CALCINEURIN; CATHEPSIN L; DIOXIN; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIGEL; MESSENGER RNA; MITOCHONDRIAL DNA; RYANODINE RECEPTOR 1; TACROLIMUS; TRANSCRIPTION FACTOR REL; TUMOR MARKER;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER INVASION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; APOPTOSIS; CALCIUM; CARCINOGENS; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; DIOXINS; DISEASE PROGRESSION; MEMBRANE POTENTIALS; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASMS; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION, GENETIC;

EID: 38349100451     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0706183104     Document Type: Article

References (45)

1. Wallace DC (2005) Annu Rev Genet 39:359-407.
2. Singh KK, Russell J, Sigala B, Zhang Y, Williams J, Keshav KF (1999) Oncogene 18:6641-6646.
3. Amuthan G, Biswas G, Zhang SY, Klein-Szanto A, Vijayasarathy C, Avadhani NG (2001) EMBO J 20:1910-1920.
4. Bandy B, Davison AJ (1990) Free Radic Biol Med 8:523-539.
5. Niranjan BG, Bhat NK, Avadhani NG (1982) Science 215:73-75.
6. Grossman LI (1995) Environ Mol Mutagen 25(Suppl 26):30 -37.
7. Biswas G, Adebanjo OA, Freedman BD, Anandatheerthavarada HK, Vijayasarathy C, Zaidi M, Kotlikoff M, Avadhani NG (1999) EMBO J 18:522-533.
8. Amuthan G, Biswas G, Ananadatheerthavarada HK, Vijayasarathy C, Shephard HM, Avadhani NG (2002) Oncogene 21:7839-7849.
9. Biswas G, Anandatheerthavarada HK, Avadhani NG (2005) Cell Death Differ 12:266-278.
10. Biswas G, Anandatheerthavarada HK, Zaidi M, Avadhani NG (2003) J Cell Biol 161:507-519.
11. Arnould T, Vankoningsloo S, Renard P, Houbion A, Ninane N, Demazy C, Remacle J, Raes M (2002) EMBO J 21:53-63.
12. Biswas G, Guha M, Avadhani NG (2005) Gene 354:132-139.
13. Butow RA, Avadhani NG (2004) Mol Cell 14:1-15.
14. Poland A, Knutson JC (1982) Annu Rev Pharmacol Toxicol 22:517-554.
15. Davis D, Safe S (1990) Toxicology 63:97-111.
16. Shen D, Dalton TP, Nebert DW, Shertzer HG (2005) J Biol Chem 280:25305-25312.
17. Senft AP, Dalton TP, Nebert DW, Genter MB, Puga A, Hutchinson RJ, Kerzee JK, Uno S, Shertzer HG (2002) Free Radic Biol Med 33:1268-1278.
18. Hassoun EA, Wang H, Abushaban A, Stohs SJ (2002) J Toxicol Environ Health 65:825-842.
19. Long WP, Perdew GH (1999) Arch Biochem Biophys 371:246-259.
20. Reiners JJ, Jr, Clift RE (1999) J Biol Chem 274:2502-2510.
21. Denhardt DT, Greenberg AH, Egan SE, Hamilton RT, Wright JA (1987) Oncogene 2:55-59.
22. Kirschke H, Eerola R, Hopsu-Havu VK, Bromme D, Vuorio E (2000) Eur J Cancer 36:787-795.
23. Long WP, Chen X, Perdew GH (1999) J Biol Chem 274:12391-12400.
24. Puga A, Barnes SJ, Chang C, Zhu H, Nephew KP, Khan SA, Shertzer HG (2000) Biochem Pharmacol 59:997-1005.
25. Stinchcombe S, Buchmann A, Bock KW, Schwarz M (1995) Carcinogenesis 16:1271-1275.
26. Davis JW, II, Lauer FT, Burdick AD, Hudson LG, Burchiel SW (2001) Cancer Res 61:3314-3320.
27. Davis JW, II, Melendez K, Salas VM, Lauer FT, Burchiel SW (2000) Carcinogenesis 21:881-886.
28. Oikawa K, Ohbayashi T, Mimura J, Iwata R, Kameta A, Evine K, Iwaya K, Fujii-Kuriyama Y, Kuroda M, Mukai K (2001) Cancer Res 61:5707-5709.
29. Tan Z, Chang X, Puga A, Xia Y (2002) Biochem Pharmacol 64:771-780.
30. Paajarvi G, Viluksela M, Pohjanvirta R, Stenius U, Hogberg J (2005) Carcinogenesis 26:201-208.
31. Long WP, Pray-Grant M, Tsai JC, Perdew GH (1998) Mol Pharmacol 53:691-700.
32. Chen Y-H, Tukey RH (1996) J Biol Chem 271:26261-26266.
33. Kallio PJ, Okamoto K, O'Brien S, Carrero P, Makino Y, Tanaka H, Poellinger L (1998) EMBO J 17:6573-6586.
34. Astroff B, Rowlands C, Dickerson R, Safe S (1990) Mol Cell Endocrinol 72:247-252.
35. Gaido KW, Maness SC, Leonard LS, Greenlee WF (1992) J Biol Chem 267:24591-24595.
36. Sutter TR, Guzman K, Dold KM, Greenlee WF (1991) Science 254:415-418.
37. Puga A, Nebert D, Carrier F (1992) DNA Cell Biol 11:269-281.
38. Silverstone AE, Frazier DE, Jr, Fiore NC, Soults JA, Gasiewicz TA (1994) Toxicol Appl Pharmacol 126:248-259.
39. Lu Y, Wang X, Safe S (1994) Toxicol Appl Pharmacol 127:1-8.
40. Sulentic CEW, Holsapple MP, Kaminski ME (2000) J Pharmacol Exp Ther 295:705-716.
41. Ashida H, Matsumura F (1998) J Biochem Mol Toxicol 12:191-204.
42. Matsumura F (2003) Biochem Pharmacol 66:527-540.
43. Weiss C, Faust D, Durk H, Kolluri SK, Pelzer A, Schneider S, Dietrich C, Oesch F, Gottlicher M (2005) Oncogene 24:4975-4983.
44. Vogel CF, Sciullo E, Park S, Liedtke C, Trautwein C, Matsumura F (2004) J Biol Chem 279:8886-8894.
45. Kantharaj GR, Bhat KS, Avadhani NG (1983) Biochemistry 22:3151-3156.